Stephen E. Zale

3.4k total citations
19 papers, 1.7k citations indexed

About

Stephen E. Zale is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Stephen E. Zale has authored 19 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Biomaterials and 4 papers in Biomedical Engineering. Recurrent topics in Stephen E. Zale's work include Nanoparticle-Based Drug Delivery (7 papers), Protein purification and stability (4 papers) and Microencapsulation and Drying Processes (3 papers). Stephen E. Zale is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), Protein purification and stability (4 papers) and Microencapsulation and Drying Processes (3 papers). Stephen E. Zale collaborates with scholars based in United States, Ireland and Puerto Rico. Stephen E. Zale's co-authors include Alexander M. Klibanov, Mark A. Tracy, Randal A. Goffe, Alexander M. Klibanov, Henry R. Costantino, Karen G. Carrasquillo, Donald M. Parsons, Kai Griebenow, Hagop Youssoufian and Dwaine F. Emerich and has published in prestigious journals such as Science, Nature Biotechnology and Biochemistry.

In The Last Decade

Stephen E. Zale

18 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen E. Zale United States 16 882 494 486 268 197 19 1.7k
Vitali Vogel Germany 22 956 1.1× 435 0.9× 728 1.5× 345 1.3× 324 1.6× 41 2.2k
Xiuling Lü United States 25 504 0.6× 581 1.2× 640 1.3× 317 1.2× 272 1.4× 78 1.9k
Bijay Kumar Poudel South Korea 31 658 0.7× 728 1.5× 866 1.8× 618 2.3× 388 2.0× 56 2.2k
Jun Shao China 18 411 0.5× 622 1.3× 350 0.7× 382 1.4× 250 1.3× 37 1.6k
Azadeh Kheirolomoom United States 28 814 0.9× 1.0k 2.0× 617 1.3× 91 0.3× 348 1.8× 71 2.3k
Sema Çalış Türkiye 26 487 0.6× 362 0.7× 734 1.5× 676 2.5× 137 0.7× 54 1.9k
Éva Kiss Hungary 25 414 0.5× 406 0.8× 418 0.9× 188 0.7× 275 1.4× 94 1.7k
Yuchen Fan China 23 1.1k 1.2× 782 1.6× 641 1.3× 315 1.2× 140 0.7× 42 2.3k
Mats Reslow Sweden 13 621 0.7× 368 0.7× 558 1.1× 530 2.0× 99 0.5× 18 1.7k
Cuifang Cai China 23 1000 1.1× 379 0.8× 646 1.3× 550 2.1× 130 0.7× 65 2.0k

Countries citing papers authored by Stephen E. Zale

Since Specialization
Citations

This map shows the geographic impact of Stephen E. Zale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. Zale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. Zale more than expected).

Fields of papers citing papers by Stephen E. Zale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen E. Zale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. Zale. The network helps show where Stephen E. Zale may publish in the future.

Co-authorship network of co-authors of Stephen E. Zale

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen E. Zale. A scholar is included among the top collaborators of Stephen E. Zale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen E. Zale. Stephen E. Zale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Foltin, Richard W., et al.. (2022). A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys. Drug and Alcohol Dependence. 239. 109599–109599. 1 indexed citations
2.
Shalgunov, Vladimir, Daria Zaytseva‐Zotova, Arkadi Zintchenko, et al.. (2017). Comprehensive study of the drug delivery properties of poly( l -lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice. Journal of Controlled Release. 261. 31–42. 52 indexed citations
3.
Hoff, Daniel D. Von, Monica Mita, Ramesh K. Ramanathan, et al.. (2016). Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors. Clinical Cancer Research. 22(13). 3157–3163. 215 indexed citations
4.
Troiano, Greg, et al.. (2016). A Quality by Design Approach to Developing and Manufacturing Polymeric Nanoparticle Drug Products. The AAPS Journal. 18(6). 1354–1365. 46 indexed citations
5.
Song, Young Ho, Hong Wang, James J. Nolan, et al.. (2016). A novel in situ hydrophobic ion pairing (HIP) formulation strategy for clinical product selection of a nanoparticle drug delivery system. Journal of Controlled Release. 229. 106–119. 73 indexed citations
6.
Banerjee, Sangeeta Ray, Catherine A. Foss, Allen Horhota, et al.. (2016). 111In- and IRDye800CW-Labeled PLA–PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues. Biomacromolecules. 18(1). 201–209. 46 indexed citations
7.
Havel, Henry A., Gregory L. Finch, Stephen E. Zale, et al.. (2016). Nanomedicines: From Bench to Bedside and Beyond. The AAPS Journal. 18(6). 1373–1378. 102 indexed citations
8.
Burgess, Paul, et al.. (2010). On firm ground: IP protection of therapeutic nanoparticles. Nature Biotechnology. 28(12). 1267–1270. 59 indexed citations
9.
Costantino, Henry R., et al.. (2004). Relationship between encapsulated drug particle size and initial release of recombinant human growth hormone from biodegradable microspheres. Journal of Pharmaceutical Sciences. 93(10). 2624–2634. 28 indexed citations
10.
Costantino, Henry R., et al.. (2002). Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability. Journal of Pharmaceutical Sciences. 91(2). 388–395. 107 indexed citations
11.
Costantino, Henry R., et al.. (2000). Protein Spray-Freeze Drying. Effect of Atomization Conditions on Particle Size and Stability. Pharmaceutical Research. 17(11). 1374–1382. 152 indexed citations
12.
Bartus, Raymond T., Mark A. Tracy, Dwaine F. Emerich, & Stephen E. Zale. (1998). Sustained Delivery of Proteins for Novel Therapeutic Products. Science. 281(5380). 1161–1162. 98 indexed citations
13.
Zhang, Yanzhong, Stephen E. Zale, Laura Sawyer, & Howard Bernstein. (1997). Effects of metal salts on poly(DL-lactide-co-glycolide) polymer hydrolysis. Journal of Biomedical Materials Research. 34(4). 531–538. 69 indexed citations
14.
Goffe, Randal A., et al.. (1988). Membrane-Based Affinity Technology for Commercial Scale Purifications. Nature Biotechnology. 6(7). 779–782. 232 indexed citations
15.
Zale, Stephen E. & Alexander M. Klibanov. (1986). Why does ribonuclease irreversibly inactivate at high temperatures?. Biochemistry. 25(19). 5432–5444. 245 indexed citations
16.
Zale, Stephen E. & Alexander M. Klibanov. (1984). Mechanisms of Irreversible Thermoinactivation of Enzymes. Annals of the New York Academy of Sciences. 434(1). 20–26. 14 indexed citations
17.
Zale, Stephen E. & Alexander M. Klibanov. (1983). On the role of reversible denaturation (unfolding) in the irreversible thermal inactivation of enzymes. Biotechnology and Bioengineering. 25(9). 2221–2230. 85 indexed citations
18.
Zale, Stephen E. & Alexander M. Klibanov. (1982). Application of immobilized hydrogenase to h2 storage in concentrated solutions of methyl viologen. Applied Biochemistry and Biotechnology. 7(5). 317–323.
19.
Klibanov, Alexander M., Barbara N. Alberti, & Stephen E. Zale. (1982). Enzymatic synthesis of formic acid from H2 and CO2 and production of hydrogen from formic acid. Biotechnology and Bioengineering. 24(1). 25–36. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vitali Vogel Breakdown of academic impact, for papers by Xiuling Lü Breakdown of academic impact, for papers by Bijay Kumar Poudel Breakdown of academic impact, for papers by Jun Shao Breakdown of academic impact, for papers by Azadeh Kheirolomoom Breakdown of academic impact, for papers by Sema Çalış Breakdown of academic impact, for papers by Éva Kiss Breakdown of academic impact, for papers by Yuchen Fan Breakdown of academic impact, for papers by Mats Reslow Breakdown of academic impact, for papers by Cuifang Cai
Rankless by CCL
2026